Taken together, our results demonstrate that downregulation of RASSF6 was responsible for the treatment resistance of highly metastatic NPC cells and that over-expression of RASSF6 and the subsequent activation of JNK signaling conferred treatment sensitivity to NPC cells. Here, MAPK8 is linked to nasopharyngeal carcinoma.